INAB — IN8BIO, INC. catalysts
Next verified catalyst
2026-12-01 — A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Au · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 26d
ESTIMATED |
READOUT
A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Alloge
Phase 1/2 · Glioblastoma |
INAB IN8BIO, INC. | Autologous genetically modified gamma-de |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-05
Sponsor-projected date — can change
|